Met Life Investment Management, LLC Aeglea Bio Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$3.5 - $8.42 $53,735 - $129,272
-15,353 Closed
0 $0
Q3 2021

May 17, 2024
SELL
$6.03 - $7.95 $29,739 - $39,209
-4,932 Reduced 24.31%
15,353 $122,000
Q3 2021

Jun 21, 2023
BUY
$6.03 - $7.95 $92,578 - $122,056
15,353 New
15,353 $122,000
Q3 2021

Mar 22, 2023
SELL
$6.03 - $7.95 $29,739 - $39,209
-4,932 Reduced 24.31%
15,353 $122,000
Q3 2021

Nov 15, 2021
BUY
$6.03 - $7.95 $92,578 - $122,056
15,353 New
15,353 $122,000
Q2 2021

Aug 16, 2021
SELL
$6.32 - $8.38 $128,201 - $169,988
-20,285 Closed
0 $0
Q1 2021

May 17, 2024
BUY
$6.76 - $8.57 $137,126 - $173,842
20,285 New
20,285 $160,000
Q1 2021

Jun 26, 2023
BUY
$6.76 - $8.57 $137,126 - $173,842
20,285 New
20,285 $161 Million
Q1 2021

Mar 22, 2023
BUY
$6.76 - $8.57 $83,114 - $105,368
12,295 Added 153.88%
20,285 $160,000
Q1 2021

May 14, 2021
BUY
$6.76 - $8.57 $83,114 - $105,368
12,295 Added 153.88%
20,285 $161,000
Q4 2020

May 24, 2024
SELL
$7.02 - $9.83 $85,229 - $119,346
-12,141 Reduced 60.31%
7,990 $62,000
Q4 2020

Jun 22, 2023
BUY
$7.02 - $9.83 $56,089 - $78,541
7,990 New
7,990 $62,000
Q4 2020

Mar 22, 2023
SELL
$7.02 - $9.83 $85,229 - $119,346
-12,141 Reduced 60.31%
7,990 $62,000
Q4 2020

Feb 16, 2021
SELL
$7.02 - $9.83 $85,229 - $119,346
-12,141 Reduced 60.31%
7,990 $63,000
Q3 2020

Jun 26, 2023
BUY
$6.51 - $9.33 $131,052 - $187,822
20,131 New
20,131 $142,000
Q2 2020

May 24, 2024
BUY
$4.01 - $11.04 $80,725 - $222,246
20,131 New
20,131 $186 Million
Q2 2020

Jun 26, 2023
BUY
$4.01 - $11.04 $80,725 - $222,246
20,131 New
20,131 $186,000
Q2 2020

Mar 22, 2023
BUY
$4.01 - $11.04 $24,035 - $66,173
5,994 Added 42.4%
20,131 $186,000
Q2 2020

Aug 14, 2020
BUY
$4.01 - $11.04 $80,725 - $222,246
20,131 New
20,131 $186,000
Q4 2019

Feb 14, 2020
SELL
$7.23 - $8.55 $102,210 - $120,871
-14,137 Closed
0 $0
Q3 2019

Jul 12, 2023
BUY
$6.42 - $9.0 $90,759 - $127,233
14,137 New
14,137 $108,000
Q3 2019

Mar 22, 2023
BUY
$6.42 - $9.0 $90,759 - $127,233
14,137 New
14,137 $108,000
Q3 2019

Nov 14, 2019
BUY
$6.42 - $9.0 $90,759 - $127,233
14,137 New
14,137 $109,000

Others Institutions Holding AGLE

# of Institutions
1
Shares Held
241K
Call Options Held
0
Put Options Held
0
View Full List

About Aeglea BioTherapeutics, Inc.

AGLE Quotes by TradingView
  • Ticker AGLE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,172,500
  • Market Cap $1.69B
  • Description
  • Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...
More about AGLE
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email